What is the equivalent dose of hydromorphone (contin) BID for a patient taking codeine (contin) 100mg twice a day (BID)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Opioid Conversion: Codeine to Hydromorphone

Convert codeine contin 100mg BID (200mg/day total) to hydromorphone contin 6-8mg BID, starting at the lower end (6mg BID) and reduce by an additional 25% for safety to 4-5mg BID.

Conversion Calculation

Step 1: Convert Codeine to Morphine Equivalents

  • Codeine 200mg/day oral converts to morphine equivalents using standard equianalgesic ratios 1
  • The conversion ratio from oral codeine to oral morphine is approximately 10:1, meaning 200mg codeine = 20mg oral morphine equivalent daily 2

Step 2: Convert Morphine to Hydromorphone

  • The conversion ratio from oral morphine to oral hydromorphone is 5:1, meaning 20mg oral morphine = 4mg oral hydromorphone daily 2
  • This yields a calculated dose of 4mg hydromorphone per day total, or 2mg BID 3

Step 3: Apply Safety Reduction for Incomplete Cross-Tolerance

  • When converting between opioids, reduce the calculated equianalgesic dose by 25-50% to account for incomplete cross-tolerance 1
  • Starting with 2mg BID and applying a conservative 25% reduction yields approximately 1.5mg BID, though this may be too low for adequate analgesia 1
  • A more practical approach: start with 2-3mg BID (the calculated dose without reduction, given codeine's relatively weak potency) 1

Critical Safety Considerations

Why This Conversion Requires Extra Caution

  • Codeine is a prodrug requiring CYP2D6 metabolism to morphine, and patients may have variable conversion efficiency, making their true opioid exposure uncertain 1
  • Hydromorphone is 5-7 times more potent than morphine, requiring careful dose calculation 4, 3
  • The patient is transitioning from a relatively weak opioid (codeine) to a potent one (hydromorphone), increasing overdose risk 1

Monitoring Protocol

  • Assess pain control and side effects within 24-48 hours of conversion 1
  • Provide breakthrough doses of immediate-release hydromorphone at 10-20% of the 24-hour dose (0.4-0.8mg every 4 hours as needed) 1, 4
  • If the patient requires more than 3 breakthrough doses per day, increase the scheduled hydromorphone contin dose 4

Bowel Management

  • Institute a stimulant laxative prophylactically, as constipation is universal with opioid therapy 4

Common Pitfalls to Avoid

  • Do not use a 1:1 conversion ratio - codeine is much weaker than hydromorphone and requires careful calculation through morphine equivalents 2
  • Do not forget the 25-50% dose reduction for incomplete cross-tolerance when switching opioids 1
  • Avoid using codeine in patients with renal failure due to accumulation of renally cleared metabolites, making hydromorphone a safer alternative 1
  • Do not combine with mixed agonist-antagonist opioids as this could precipitate withdrawal 1, 4

Alternative Consideration

  • Given the relatively low opioid requirement (codeine 200mg/day is a modest dose), consider whether the patient truly requires long-acting opioid therapy or if immediate-release hydromorphone with appropriate breakthrough dosing might be more appropriate initially 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid Conversion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hydromorphone Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.